Comparing Ketamine, Propofol, and Their Combination for Rapid Sequence Induction During Surgery A 3-Group Randomized Study
Led by Nantes University Hospital · Updated on 2025-12-02
1218
Participants Needed
20
Research Sites
2 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the best hypnotic drug to balance good intubation quality and stable blood pressure during rapid sequence induction RSI in the operating room. This Phase 3 randomized study compares the effects of propofol, ketamine, and a combination of both drugs for patients needing RSI under general anesthesia. The main goal is to see which option allows successful intubation on the first attempt without causing major drops in blood pressure.
Participants will receive one of three treatments after pre-oxygenation a direct intravenous injection of propofol at 2 mgkg, ketamine at 2 mgkg, or a combination of ketamine 1 mgkg followed by propofol 1 mgkg. The combination treatment does not require dilution. These treatments are given consecutively in the operating theater and monitored closely during the procedure.
During the study, participants will be assessed for successful intubation and blood pressure stability within 10 minutes after hypnotic injection. Researchers will also monitor heart rate, oxygen levels, fluid and medication use, and any complications such as pulmonary aspiration. Tolerance to the drugs will be followed during the recovery room stay and up to seven days after surgery. The study runs from April 2025 to April 2027 and includes detailed safety and effectiveness measurements.
CONDITIONS
Brief Title
Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room
Research Team
N
Nicolas GRILLOT, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
At least one risk factor for aspiration of gastric contents such as fasting less than 6 hours, recent vomiting, orthopedic trauma within 12 hours, or history of gastroesophageal reflux or related conditions
Requires orotracheal intubation during general anesthesia in the operating room
Provided written informed consent or emergency procedure consent
Failure to discontinue GLP1 analogues as recommended
You will not qualify if you...
Predicted impossible tracheal intubation due to known complications or specific airway measurements
Preoperative arterial hypotension (mean arterial pressure under 65 mmHg or on catecholamines)
Preoperative respiratory distress (oxygen saturation under 90% in room air)
Contraindications to ketamine, propofol, or neuromuscular blockers including allergies, porphyria, intracranial hypertension, uncontrolled high blood pressure, malignant hyperthermia history, muscular dystrophy, myasthenia, or plasma pseudocholinesterase deficiency
Pregnancy or breastfeeding
Under court protection or guardianship
No health insurance coverage for costs
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Single treatment event on the day of surgery
Participants receive one of three hypnotic drug regimens by direct IV injection after pre-oxygenation for rapid sequence induction during general anesthesia in the operating room.
1 procedure visit (in-person)
Follow-up
Duration - Up to 7 days after induction
Participants are monitored for tolerance and recovery in the recovery room and up to 7 days after induction.
Approximately 1 to 2 visits during recovery room stay and follow-up
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Best hypnotic drug choice for rapid sequence induction in the operating room: study protocol for a 3-arm superiority open-labeled randomized controlled trial with blinded evaluation of the primary outcome (the HyPnotiKs study).
Nicolas Grillot, Christelle Volteau, Pauline Quillet...